Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

PHAS

PhaseBio Pharmaceuticals (PHAS)

PhaseBio Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PHAS
DateTimeSourceHeadlineSymbolCompany
31/05/202306:03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
20/05/202306:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
20/05/202306:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
20/05/202306:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
20/05/202306:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
17/05/202306:23Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
04/04/202306:06Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
24/03/202323:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
15/02/202309:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
15/02/202307:01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
15/02/202306:27Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
24/12/202200:34Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
21/12/202222:10Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
03/12/202208:20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
16/11/202208:21Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
05/11/202207:44Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
01/11/202208:22Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
27/10/202207:42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
24/10/202223:00Business WirePhaseBio Plans for Near-Term Sale Using Structured Process Through Chapter 11 of U.S. Bankruptcy CodeNASDAQ:PHASPhaseBio Pharmaceuticals Inc
08/10/202208:22Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
29/09/202202:05TipRanksPhasebio Pharmaceuticals (PHAS) was downgraded to a Hold Rating at NeedhamNASDAQ:PHASPhaseBio Pharmaceuticals Inc
28/09/202207:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
15/08/202220:15TipRanksH.C. Wainwright Keeps Their Buy Rating on Phasebio Pharmaceuticals (PHAS)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
13/08/202206:15TipRanksPhasebio Pharmaceuticals (PHAS) Receives a Buy from NeedhamNASDAQ:PHASPhaseBio Pharmaceuticals Inc
12/08/202222:34Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
12/08/202222:30Business WirePhaseBio Pharmaceuticals Reports Second Quarter 2022 Financial Results and Recent Business HighlightsNASDAQ:PHASPhaseBio Pharmaceuticals Inc
06/07/202206:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
16/06/202222:18TipRanks10 Penny Stocks that Could Deliver Exponential ReturnsNASDAQ:PHASPhaseBio Pharmaceuticals Inc
25/05/202207:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
25/05/202207:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:PHAS